Report cover image

Lung Cancer Drugs Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type

Publisher Prof-Research
Published Jan 01, 2025
Length 93 Pages
SKU # PROF19484537

Description

Lung Cancer Drugs Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type


This report describes the global market size of Lung Cancer Drugs from 2020 to 2024 and its CAGR from 2020 to 2024, and also forecasts its market size to the end of 2030 and its CAGR from 2025 to 2030.

For geography segment, regional supply, demand, major players, price is presented from 2020 to 2030. This report cover following regions:
North America
South America
Asia & Pacific
Europe
MEA

The key countries for each regions are also included such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For competitor segment, the report include global key players of Lung Cancer Drugs as well as some small players. The information for each competitor include:
Company Profile
Business Information
SWOT Analysis
Revenue, Gross Margin and Market Share

Types Segment:
cemiplimab
pembrolizumab
nivolumab
atezolizumab
durvalumab
avelumab
Others

Companies Covered:
Regeneron Pharmaceuticals/Sanofi
Merck
Bristol-Myers Squibb
Roche
AstraZeneca
Pfizer
etc.

Please ask for sample pages for full companies list

Base Year: 2025
Historical Data: from 2020 to 2024
Forecast Data: from 2025 to 2030

Table of Contents

93 Pages
Chapter 1 Executive Summary
Chapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter Four Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 Covid-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Lung Cancer Drugs Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Lung Cancer Drugs Market in North America (2020-2030)
8.1 Lung Cancer Drugs Market Size
8.2 Lung Cancer Drugs Market by End Use
8.3 Competition by Players/Suppliers
8.4 Lung Cancer Drugs Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Lung Cancer Drugs Market in South America (2020-2030)
9.1 Lung Cancer Drugs Market Size
9.2 Lung Cancer Drugs Market by End Use
9.3 Competition by Players/Suppliers
9.4 Lung Cancer Drugs Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Lung Cancer Drugs Market in Asia & Pacific (2020-2030)
10.1 Lung Cancer Drugs Market Size
10.2 Lung Cancer Drugs Market by End Use
10.3 Competition by Players/Suppliers
10.4 Lung Cancer Drugs Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southest Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Lung Cancer Drugs Market in Europe (2020-2030)
11.1 Lung Cancer Drugs Market Size
11.2 Lung Cancer Drugs Market by End Use
11.3 Competition by Players/Suppliers
11.4 Lung Cancer Drugs Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Lung Cancer Drugs Market in MEA (2020-2030)
12.1 Lung Cancer Drugs Market Size
12.2 Lung Cancer Drugs Market by End Use
12.3 Competition by Players/Suppliers
12.4 Lung Cancer Drugs Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Lung Cancer Drugs Market (2020-2025)
13.1 Lung Cancer Drugs Market Size
13.2 Lung Cancer Drugs Market by End Use
13.3 Competition by Players/Suppliers
13.4 Lung Cancer Drugs Market Size by Type
Chapter 14 Global Lung Cancer Drugs Market Forecast (2025-2030)
14.1 Lung Cancer Drugs Market Size Forecast
14.2 Lung Cancer Drugs Application Forecast
14.3 Competition by Players/Suppliers
14.4 Lung Cancer Drugs Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Regeneron Pharmaceuticals/Sanofi
15.1.1 Company Profile
15.1.2 Main Business and Lung Cancer Drugs Information
15.1.3 SWOT Analysis of Regeneron Pharmaceuticals/Sanofi
15.1.4 Regeneron Pharmaceuticals/Sanofi Lung Cancer Drugs Revenue, Gross Margin and Market Share (2020-2025)
15.2 Merck
15.2.1 Company Profile
15.2.2 Main Business and Lung Cancer Drugs Information
15.2.3 SWOT Analysis of Merck
15.2.4 Merck Lung Cancer Drugs Revenue, Gross Margin and Market Share (2020-2025)
15.3 Bristol-Myers Squibb
15.3.1 Company Profile
15.3.2 Main Business and Lung Cancer Drugs Information
15.3.3 SWOT Analysis of Bristol-Myers Squibb
15.3.4 Bristol-Myers Squibb Lung Cancer Drugs Revenue, Gross Margin and Market Share (2020-2025)
15.4 Roche
15.4.1 Company Profile
15.4.2 Main Business and Lung Cancer Drugs Information
15.4.3 SWOT Analysis of Roche
15.4.4 Roche Lung Cancer Drugs Revenue, Gross Margin and Market Share (2020-2025)
15.5 AstraZeneca
15.5.1 Company Profile
15.5.2 Main Business and Lung Cancer Drugs Information
15.5.3 SWOT Analysis of AstraZeneca
15.5.4 AstraZeneca Lung Cancer Drugs Revenue, Gross Margin and Market Share (2020-2025)
15.6 Pfizer
15.6.1 Company Profile
15.6.2 Main Business and Lung Cancer Drugs Information
15.6.3 SWOT Analysis of Pfizer
15.6.4 Pfizer Lung Cancer Drugs Revenue, Gross Margin and Market Share (2020-2025)
Please ask for sample pages for full companies list
 
Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Lung Cancer Drugs Report
Table Data Sources of Lung Cancer Drugs Report
Table Major Assumptions of Lung Cancer Drugs Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Lung Cancer Drugs Picture
Table Lung Cancer Drugs Classification
Table Lung Cancer Drugs Applications
Table Drivers of Lung Cancer Drugs Market
Table Restraints of Lung Cancer Drugs Market
Table Opportunities of Lung Cancer Drugs Market
Table Threats of Lung Cancer Drugs Market
Table Covid-19 Impact For Lung Cancer Drugs Market
Table Raw Materials Suppliers
Table Different Production Methods of Lung Cancer Drugs
Table Cost Structure Analysis of Lung Cancer Drugs
Table Key End Users
Table Latest News of Lung Cancer Drugs Market
Table Merger and Acquisition
Table Planned/Future Project of Lung Cancer Drugs Market
Table Policy of Lung Cancer Drugs Market
Table 2020-2030 North America Lung Cancer Drugs Market Size
Figure 2020-2030 North America Lung Cancer Drugs Market Size and CAGR
Table 2020-2030 North America Lung Cancer Drugs Market Size by Application
Table 2020-2025 North America Lung Cancer Drugs Key Players Revenue
Table 2020-2025 North America Lung Cancer Drugs Key Players Market Share
Table 2020-2030 North America Lung Cancer Drugs Market Size by Type
Table 2020-2030 United States Lung Cancer Drugs Market Size
Table 2020-2030 Canada Lung Cancer Drugs Market Size
Table 2020-2030 Mexico Lung Cancer Drugs Market Size
Table 2020-2030 South America Lung Cancer Drugs Market Size
Figure 2020-2030 South America Lung Cancer Drugs Market Size and CAGR
Table 2020-2030 South America Lung Cancer Drugs Market Size by Application
Table 2020-2025 South America Lung Cancer Drugs Key Players Revenue
Table 2020-2025 South America Lung Cancer Drugs Key Players Market Share
Table 2020-2030 South America Lung Cancer Drugs Market Size by Type
Table 2020-2030 Brazil Lung Cancer Drugs Market Size
Table 2020-2030 Argentina Lung Cancer Drugs Market Size
Table 2020-2030 Chile Lung Cancer Drugs Market Size
Table 2020-2030 Peru Lung Cancer Drugs Market Size
Table 2020-2030 Asia & Pacific Lung Cancer Drugs Market Size
Figure 2020-2030 Asia & Pacific Lung Cancer Drugs Market Size and CAGR
Table 2020-2030 Asia & Pacific Lung Cancer Drugs Market Size by Application
Table 2020-2025 Asia & Pacific Lung Cancer Drugs Key Players Revenue
Table 2020-2025 Asia & Pacific Lung Cancer Drugs Key Players Market Share
Table 2020-2030 Asia & Pacific Lung Cancer Drugs Market Size by Type
Table 2020-2030 China Lung Cancer Drugs Market Size
Table 2020-2030 India Lung Cancer Drugs Market Size
Table 2020-2030 Japan Lung Cancer Drugs Market Size
Table 2020-2030 South Korea Lung Cancer Drugs Market Size
Table 2020-2030 Southeast Asia Lung Cancer Drugs Market Size
Table 2020-2030 Australia Lung Cancer Drugs Market Size
Table 2020-2030 Europe Lung Cancer Drugs Market Size
Figure 2020-2030 Europe Lung Cancer Drugs Market Size and CAGR
Table 2020-2030 Europe Lung Cancer Drugs Market Size by Application
Table 2020-2025 Europe Lung Cancer Drugs Key Players Revenue
Table 2020-2025 Europe Lung Cancer Drugs Key Players Market Share
Table 2020-2030 Europe Lung Cancer Drugs Market Size by Type
Table 2020-2030 Germany Lung Cancer Drugs Market Size
Table 2020-2030 France Lung Cancer Drugs Market Size
Table 2020-2030 United Kingdom Lung Cancer Drugs Market Size
Table 2020-2030 Italy Lung Cancer Drugs Market Size
Table 2020-2030 Spain Lung Cancer Drugs Market Size
Table 2020-2030 Belgium Lung Cancer Drugs Market Size
Table 2020-2030 Netherlands Lung Cancer Drugs Market Size
Table 2020-2030 Austria Lung Cancer Drugs Market Size
Table 2020-2030 Poland Lung Cancer Drugs Market Size
Table 2020-2030 Russia Lung Cancer Drugs Market Size
Table 2020-2030 MEA Lung Cancer Drugs Market Size
Figure 2020-2030 MEA Lung Cancer Drugs Market Size and CAGR
Table 2020-2030 MEA Lung Cancer Drugs Market Size by Application
Table 2020-2025 MEA Lung Cancer Drugs Key Players Revenue
Table 2020-2025 MEA Lung Cancer Drugs Key Players Market Share
Table 2020-2030 MEA Lung Cancer Drugs Market Size by Type
Table 2020-2030 Egypt Lung Cancer Drugs Market Size
Table 2020-2030 Israel Lung Cancer Drugs Market Size
Table 2020-2030 South Africa Lung Cancer Drugs Market Size
Table 2020-2030 Gulf Cooperation Council Countries Lung Cancer Drugs Market Size
Table 2020-2030 Turkey Lung Cancer Drugs Market Size
Table 2020-2025 Global Lung Cancer Drugs Market Size by Region
Table 2020-2025 Global Lung Cancer Drugs Market Size Share by Region
Table 2020-2025 Global Lung Cancer Drugs Market Size by Application
Table 2020-2025 Global Lung Cancer Drugs Market Share by Application
Table 2020-2025 Global Lung Cancer Drugs Key Vendors Revenue
Figure 2020-2025 Global Lung Cancer Drugs Market Size and Growth Rate
Table 2020-2025 Global Lung Cancer Drugs Key Vendors Market Share
Table 2020-2025 Global Lung Cancer Drugs Market Size by Type
Table 2020-2025 Global Lung Cancer Drugs Market Share by Type
Table 2025-2030 Global Lung Cancer Drugs Market Size by Region
Table 2025-2030 Global Lung Cancer Drugs Market Size Share by Region
Table 2025-2030 Global Lung Cancer Drugs Market Size by Application
Table 2025-2030 Global Lung Cancer Drugs Market Share by Application
Table 2025-2030 Global Lung Cancer Drugs Key Vendors Revenue
Figure 2025-2030 Global Lung Cancer Drugs Market Size and Growth Rate
Table 2025-2030 Global Lung Cancer Drugs Key Vendors Market Share
Table 2025-2030 Global Lung Cancer Drugs Market Size by Type
Table 2025-2030 Lung Cancer Drugs Global Market Share by Type

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us